An extensive analysis performed on 2048 CRC patients has demonstrated an association between high CD166 expression and a higher patient age, along with a poor degree of tumor differentiation (HR = 1.29, 95%CI = 1.01–1.29, p = 0.05) [30] (Table 7). The gene discussed is ALCAM; the disease is colorectal carcinoma.